Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00218101
Status:
COMPLETED
Last Update Posted:
2017-01-12
First Post:
2005-09-16
Brief Title:
Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Dose Reduction Strategies in Oral Opioid Dependence Subsequent to Pain Management An Exploratory Study
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Opioids used to treat chronic pain have a high abuse potential The purpose of this study is to determine the effectiveness of buprenorphine in treating opioid dependent individuals who abuse opioids that are prescribed for chronic pain
Detailed Description:
Many individuals who take opioids for chronic pain abuse the opioid medication Buprenorphine is an opioid partial agonist that may be effective in treating individuals who abuse opiate pain medication The purpose of this study is to compare two buprenorphine dosing regimens in order to determine which regimen is more effective in reducing opiate pain medication use and facilitating successful opioid detoxification
This study will last 27 weeks Participants will receive a maintenance dose of 8 mg of buprenorphine for 6 weeks followed by a dose reduction in 2 mg increments over the course of the following 20 weeks All participants will attend weekly clinical management sessions for the duration of the study
This study will last 27 weeks Participants will receive a maintenance dose of 8 mg of buprenorphine for 6 weeks followed by a dose reduction in 2 mg increments over the course of the following 20 weeks All participants will attend weekly clinical management sessions for the duration of the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DPMC | None | None | None |
| P50-09262-11 | None | None | None |